Health / Health News |
Autoimmune Disease Super-Regulators Uncovered
NIH | MARCH 20, 2015
The immune system has a complex, delicately orchestrated balance. White blood cells called CD4 T cells can mature to become many types of T cells, each of which has a distinct function. Some activate immune responses; others constrain immune responses. When the system is out of balance, uncontrolled reactions can lead to attacks against the body’s own cells and tissues and cause autoimmune disease.
A research team led by Drs. Golnaz Vahedi and John J. O’Shea at NIH’s National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) investigated the role of a recently discovered type of genetic regulatory element called super-enhancers, or stretch-enhancers (SE). The team searched the genome of T cells for regions bound by a protein called histone acetyltransferase p300, which marks DNA segments that carry SEs.
The dominant gene class associated with SEs in T cells encoded cytokines and cytokine receptors. These allow T cells to communicate with other cells and coordinate the immune response. When the scientists exposed human T cells to tofacitinib—a drug used to treat rheumatoid arthritis—the activities of many genes controlled by SEs were preferentially affected.
Three types of data—the genetics of rheumatoid arthritis, a genomic feature of T cells, and the pharmacological effects of a rheumatoid arthritis drug—are all pointing to the importance of super-enhancers.